RITEDOSE PHARMACEUTICALS

Serial Number 90136326
Registration 6854964
700

Registration Progress

Application Filed
Aug 25, 2020
Under Examination
Nov 9, 2021
Approved for Publication
Sep 14, 2021
Published for Opposition
Sep 14, 2021
Registered
Sep 27, 2022

Trademark Image

RITEDOSE PHARMACEUTICALS

Basic Information

Serial Number
90136326
Registration Number
6854964
Filing Date
August 25, 2020
Registration Date
September 27, 2022
Published for Opposition
September 14, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 27, 2022
Registration
Registered
Classes
005

Rights Holder

THE RITEDOSE CORPORATION

03
Address
1 TECHNOLOGY CIR
COLUMBIA, SC 29203

Ownership History

THE RITEDOSE CORPORATION

Original Applicant
03
COLUMBIA, SC

THE RITEDOSE CORPORATION

Owner at Publication
03
COLUMBIA, SC

THE RITEDOSE CORPORATION

Original Registrant
03
COLUMBIA, SC

Application History

39 events
Date Code Type Description Documents
Jan 1, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Sep 27, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 27, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 26, 2022 MREI E NOTICE OF REINSTATEMENT E-MAILED Loading...
Aug 25, 2022 DP1B I 1(B) BASIS DELETED; PROCEED TO REGISTRATION Loading...
Aug 25, 2022 RGIA O REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED Loading...
Aug 22, 2022 APET A ASSIGNED TO PETITION STAFF Loading...
Aug 12, 2022 ERRS I TEAS REQUEST FOR REINSTATEMENT Loading...
Jun 13, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 13, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 9, 2022 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Nov 9, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 14, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 14, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 14, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 14, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 26, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 26, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 26, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 11, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 11, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 11, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 11, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Aug 11, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 26, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 26, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 26, 2021 ALIE A ASSIGNED TO LIE Loading...
Jul 19, 2021 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Jul 19, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 19, 2021 PETG O PETITION TO REVIVE-GRANTED Loading...
Jul 19, 2021 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Jul 12, 2021 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jul 12, 2021 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Dec 29, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 29, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 29, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 21, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 28, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 28, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical oral liquid preparations for the treatment of colds, allergies, coughs, sinus ailments, fevers, gastrointestinal ailments, digestive ailments, cardiovascular ailments, circulatory ailments, blood anomalies, respiratory ailments, muscular-skeletal disorders, eye disorders, oral-ear-nose and throat problems, parasitic problems, endocrine problems, male and female sexual performance problems, reproductive system problems, urologic and urinary tract problems, hormone deficiencies, skin disorders, infections, neurological problems, insomnia, hair loss, immunologic ailments; Pharmaceutical oral liquid preparations in the nature of analgesics for pain management; Pharmaceutical oral liquid preparations in the nature of oral contraceptives; Blow fill seal containers for medical use sold filled with pharmaceutical oral liquid preparations for the treatment of colds, allergies, coughs, sinus ailments, fevers, gastrointestinal ailments, digestive ailments, cardiovascular ailments, circulatory ailments, blood anomalies, respiratory ailments, muscular-skeletal disorders, eye disorders, oral-ear-nose and throat problems, parasitic problems, endocrine problems, male and female sexual performance problems, reproductive system problems, urologic and urinary tract problems, hormone deficiencies, skin disorders, infections, neurological problems, insomnia, hair loss, immunologic ailments
First Use Anywhere: Feb 1, 2012
First Use in Commerce: Feb 1, 2012

Additional Information

Pseudo Mark
RITE DOSE PHARMACEUTICALS; RIGHT DOSE PHARMACEUTICALS

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"